Engineering the microbiome to prevent adverse events: challenges and opportunities

S Khan, R Hauptman, L Kelly - Annual review of pharmacology …, 2021 - annualreviews.org
In the past decade of microbiome research, we have learned about numerous adverse
interactions between the microbiome and medical interventions such as drugs, radiation …

Engineering the Microbiome to Prevent Adverse Events: Challenges and Opportunities

S Khan, R Hauptman, L Kelly - Annual Review of …, 2021 - einstein.elsevierpure.com
In the past decade of microbiome research, we have learned about numerous adverse
interactions between the microbiome and medical interventions such as drugs, radiation …

[HTML][HTML] Engineering the Microbiome to Prevent Adverse Events: Challenges and Opportunities

S Khan, R Hauptman, L Kelly - Annual review of pharmacology …, 2021 - ncbi.nlm.nih.gov
In the past decade of microbiome research, we have learned about numerous adverse
interactions between the microbiome and medical interventions such as drugs, radiation …

Engineering the Microbiome to Prevent Adverse Events: Challenges and Opportunities.

S Khan, R Hauptman, L Kelly - Annual Review of Pharmacology …, 2020 - europepmc.org
In the past decade of microbiome research, we have learned about numerous adverse
interactions between the microbiome and medical interventions such as drugs, radiation …

Engineering the Microbiome to Prevent Adverse Events: Challenges and Opportunities

S Khan, R Hauptman, L Kelly - Annual review of …, 2021 - pubmed.ncbi.nlm.nih.gov
In the past decade of microbiome research, we have learned about numerous adverse
interactions between the microbiome and medical interventions such as drugs, radiation …